Erratum: Do high levels of n-3 polyunsaturated fatty acids in cell membranes increase the risk of postoperative atrial fibrillation? (Cardiology (2013) 126 (107-114) DOI: 10.1159/000351432);Do high levels of n-3 polyunsaturated fatty acids in cell membranes increase the risk of postoperative atrial fibrillation?

Cardiology (Switzerland)

Volumn 126, Issue 2, 2013, Pages 107-114

  Bjorgvinsdottir, Lara ^a   Arnar, David O ^a,b   Indridason, Olafur S ^b   Heidarsdottir, Ragnhildur ^a   Skogstrand, Kristin ^b   Torfason, Bjarni ^a,c   Hougaard, David M ^b   Palsson, Runolfur ^a,b   Skuladottir, Gudrun V ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c STATENS SERUM INSTITUT   (Denmark)

Author keywords

Atrial fibrillation; Inflammation; n 3 polyunsaturated fatty acids; Postoperative

Indexed keywords

DOCOSAHEXAENOIC ACID; GAMMA INTERFERON; ICOSAPENTAENOIC ACID; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; OMEGA 3 FATTY ACID;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; FATTY ACID BLOOD LEVEL; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINUS RHYTHM;

AGED; ATRIAL FIBRILLATION; CARDIOPULMONARY BYPASS; CYTOKINES; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; ERYTHROCYTE MEMBRANE; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84885084301     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000445223     Document Type: Erratum

References (35)

1. Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, Collins JJ, Cohn LH, Burstin HR: Predictors of atrial fibrillation after coronary artery surgery. Circulation 1996; 94: 390-397.
2. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, Barash PG, Hsu PH, Mangano DT: A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004; 291: 1720-1729.
3. Laffey JG, Boylan JF, Cheng DC: The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 2002; 97: 215-252.
4. Anselmi A, Possati G, Gaudino M: Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causation? Ann Thorac Surg 2009; 88: 326-333.
5. Kaireviciute D, Blann AD, Balakrishnan B, Lane DA, Patel JV, Uzdavinys G, Norkunas G, Kalinauskas G, Sirvydis V, Aidietis A, Lip GY: Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients. Thromb Haemost 2010; 104: 122-127.
6. Bruins P, te Velthuis H, Yazdanbakhsh AP, Jansen PG, van Hardevelt FW, de Beaumont EM, Wildevuur CR, Eijsman L, Trouwborst A, Hack C: Activation of the complement system during and after cardiopulmonary bypass surgery: post surgery activation involves Creactive protein and is associated with postoperative arrhythmia. Circulation 1997; 96: 3542-3548.
7. Maisel WH, Rawn JD, Stevenson WG: Atrial fibrillation after cardiac surgery. Ann Intern Med 2001; 135: 1061-1073.
8. Skuladottir GV, Heidarsdottir R, Arnar DO, Torfason B, Edvardsson V, Gottskalksson G, Palsson R, Indridason O: Plasma n-3 and n-6 fatty acids and the incidence of atrial fibrillation following coronary artery bypass graft surgery. Eur J Clin Invest 2011; 41: 995-1003.
9. Calder PC: n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006; 83: 1505S-1519S.
10. Ariel A, Serhan CN: Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 2007; 28: 176-183.
11. Chapkin RS, Kim W, Lupton JR, McMurray DN: Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids 2009; 8: 187-191.
12. Leaf A, Kang JX, Xiao YF, Billman GE: Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003; 107: 2646-2652.
13. Li G-R, Sun HY, Zhang ZH, Cheng LC, Chiu SW, Tse HF, Lau CP: Omega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K + currents and Na + current in human atrial myocytes. Cardiovasc Res 2009; 81: 286-293.
14. Kumar S, Sutherland F, Rosso R, Teh AW, Lee G, Heck PM, Feldman A, Medi C, Watt S, Garg ML, Sparks PB: Effects of chronic omega-3 polyunsaturated fatty acid supplementation on human atrial electrophysiology. Heart Rhythm 2011; 8: 562-568.
15. Savelieva I, Camm AJ: Polyunsaturated fatty acids for prevention of atrial fibrillation: a 'fishy' story. Europace 2011; 13: 149-152.
16. Calo L, Bianconi L, Colivicchi F, Lamberti F, Loricchio ML, de Ruvo E, Meo A, Pandozi C, Staibano M, Santini M: N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol 2005; 45: 1723-1728.
17. Heidt MC, Vician M, Stracke SK, Stadlbauer T, Grebe MT, Boening A, Vogt PR, Erdogan A: Beneficial effects of intravenously administered N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a prospective randomized study. Thorac Cardiovasc Surg 2009; 57: 276-280.
18. Saravanan P, Bridgewater B, West AL, O'Neill SC, Calder PC, Davidson NC: Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ Arrhythm Electrophysiol 2010; 3: 46-53.
19. Heidarsdottir R, Arnar DO, Skuladottir GV, Torfason B, Edvardsson V, Gottskalksson G, Palsson R, Indridason OS: Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery? Europace 2010; 12: 356-363.
20. Farquharson AL, Metcalf RG, Sanders P, Stuklis R, Edwards JR, Gibson RA, Cleland LG, Sullivan TR, James MJ, Young GD: Effect of dietary fish oil on atrial fibrillation after cardiac surgery. Am J Cardiol 2011; 108: 851-856.
21. Nattel S, Van Wagoner D: Atrial fibrillation: therapy with omega-3 fatty acids-is the case closed? Nat Rev Cardiol 2011; 8: 126-128.
22. Metcalf RG, Cleland LG, Gibson RA, Roberts-Thomson KC, Edwards JR, Sanders P, Stuklis R, James MJ, Young GD: Relation between blood and atrial fatty acids in patients undergoing cardiac bypass surgery. Am J Clin Nutr 2010; 91: 528-534.
23. Katan MB, Deslypere JP, van Birgelen AP, Penders M, Zegwaard M: Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res 1997; 38: 2012-2022.
24. Skogstrand K, Thorsen P, Norgaard-Pedersen B, Schendel DE, Sorensen LC, Hougaard DM: Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 2005; 51: 1854-1866.
25. Bligh EG, Dyer WJ: A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917.
26. Wu JH, Lemaitre RN, King IB, Song X, Sacks FM, Rimm EB, Heckbert SR, Siscovick DS, Mozaffarian D: Association of plasma phospholipid long-chain omega-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study. Circulation 2012; 125: 1084-1093.
27. Liu T, Korantzopoulos P, Shehata M, Li G, Wang X, Kaul S: Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials. Heart 2011; 97: 1034-1040.
28. Virtanen JK, Mursu J, Voutilainen S, Tuomainen TP: Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men. Circulation 2009; 120: 2315-2321.
29. Mozaffarian D, Marchioli R, Macchia A, Silletta MG, Ferrazzi P, Gardner T, Latini R, Libby P, Lombardi F, O'Gara P, Page R, Tavazzi L, Tognoni G, OPERA Investigators: Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation (OPERA) randomized trial. JAMA 2012; 308: 2001-2011.
30. Macchia A, Grancelli H, Varini S, Nul D, Laffaye N, Mariani J, Ferrante D, Badra R, Figal J, Ramos S, Tognoni G, Doval HC, GESICA Investigators: Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial. J Am Coll Cardiol 2013; 61: 463-468.
31. Sands SA, Reid KJ, Windsor SL, Harris WS: The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids 2005; 40:343-347.
32. Camm AJ, Savelieva I: Fish oil for secondary prevention of atrial fibrillation: should we still believe in its anti-arrhythmic effect? Circulation 2011; 124: 1093-1096.
33. Den Ruitjer HM, Berecki G, Opthof T, Verkerk AO, Zock PL, Coronel R: Pro-and antiarrhythmic properties of a diet rich in fish oils. Cardiovasc Res 2007; 73: 316-325.
34. Wilhelm M, Tobias R, Asskali F, Kraechner R, Kuly S, Klinghammer L, Boehles H, Daniel WG: Red blood cell omega-3 fatty acids and the risk of ventricular arrhythmias in patients with heart failure. Am Heart J 2008; 155: 971-977.
35. Helgadottir S, Sigurdsson MI, Ingvarsdottir IL, Arnar DO, Gudbjartsson T: Atrial fibrillation following cardiac surgery: risk analysis and long term survival. J Cardiothorac Surg 2012; 7:87-93.